Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and ProMIS Neurosciences (PMN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Butterfly Network (BFLY – Research Report) and ProMIS Neurosciences (PMN – Research Report) with bullish sentiments.

TipRanks Black Friday Sale

• Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
• Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

Butterfly Network (BFLY)

In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Butterfly Network. The company’s shares closed last Tuesday at $1.96.

According to TipRanks.com, Knickerbocker is a 5-star analyst with an average return of 30.3% and a 57.9% success rate. Knickerbocker covers the Healthcare sector, focusing on stocks such as Phathom Pharmaceuticals, Avadel Pharmaceuticals, and Diamedica Therapeutics. ;'>

Butterfly Network has an analyst consensus of Strong Buy, with a price target consensus of $3.75, which is a 96.3% upside from current levels. In a report released today, Lake Street also maintained a Buy rating on the stock with a $4.00 price target.

See the top stocks recommended by analysts >>

ProMIS Neurosciences (PMN)

In a report released yesterday, Eddie Hickman from Guggenheim reiterated a Buy rating on ProMIS Neurosciences, with a price target of $5.00. The company’s shares closed last Tuesday at $0.36.

According to TipRanks.com, Hickman is a 4-star analyst with an average return of 19.2% and a 60.7% success rate. Hickman covers the Healthcare sector, focusing on stocks such as Outlook Therapeutics, Immunovant, and Cybin. ;'>

Currently, the analyst consensus on ProMIS Neurosciences is a Moderate Buy with an average price target of $4.00, implying a 1036.4% upside from current levels. In a report issued on November 12, Maxim Group also maintained a Buy rating on the stock with a $3.00 price target.

Read More on BFLY:

Disclaimer & DisclosureReport an Issue

• Strategic Partnership and Financial Prospects Drive Buy Rating for Butterfly Network
• Butterfly Network Signs Licensing Deal with Midjourney
• Unusually active option classes on open November 7th
• Butterfly Network’s Earnings Call: Mixed Sentiments and Optimistic Outlook
• Butterfly Network price target raised to $3.25 from $2 at Craig-Hallum